Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127198181 | 12719818 | 1 | I | 20160831 | 20160907 | 20160907 | EXP | DE-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK024157 | GLENMARK | EFFERTH T, SCHOTTLER U, KRISHNA S, SCHMIEDEK P, WENZ F, GIORDANO F A.. HEPATOTOXICITY BY COMBINATION TREATMENT OF TEMOZOLOMIDE, ARTESUNATE AND CHINESE HERBS IN A GLIOBLASTOMA MULTIFORME PATIENT: CASE REPORT REVIEW OF THE LITERATURE.. ARCHIVES OF TOXICOLOGY. 2016;1-14 | 65.00 | YR | Y | 0.00000 | 20160907 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127198181 | 12719818 | 1 | PS | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | U | 0 | |||||||||
| 127198181 | 12719818 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 127198181 | 12719818 | 3 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 127198181 | 12719818 | 4 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 127198181 | 12719818 | 5 | SS | ARTESUNATE | ARTESUNATE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127198181 | 12719818 | 6 | SS | CLOBAZAM | CLOBAZAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 127198181 | 12719818 | 7 | SS | DECOCTION OF CHINESE HERBS | HERBALS | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127198181 | 12719818 | 8 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127198181 | 12719818 | 1 | Product used for unknown indication |
| 127198181 | 12719818 | 2 | Product used for unknown indication |
| 127198181 | 12719818 | 3 | Product used for unknown indication |
| 127198181 | 12719818 | 4 | Product used for unknown indication |
| 127198181 | 12719818 | 5 | Product used for unknown indication |
| 127198181 | 12719818 | 6 | Product used for unknown indication |
| 127198181 | 12719818 | 7 | Product used for unknown indication |
| 127198181 | 12719818 | 8 | Glioblastoma multiforme |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127198181 | 12719818 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127198181 | 12719818 | Condition aggravated | |
| 127198181 | 12719818 | Hepatotoxicity | |
| 127198181 | 12719818 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |